Accessibility Links

Skip to main contentAccessibility help
Accessibility feedback
Press / to jump to the search box
Choose what you’re giving feedback on
  • Delete

  • See more
  • Delete

  • See more
  • Report inappropriate predictions
    Quick Settings
    Sign in

    Filters and Topics

    AI Mode
    All
    Shopping
    Images
    Short videos
    Videos
    Forums
    More
    News
    Web
    Books
    Maps
    Tools
    Any time
    Any time
    Past hour
    Past 24 hours
    Past week
    Past month
    Past year
    Custom range...
    Custom date range
    Go
    All results
    All results
    Verbatim
    Advanced Search
    About 101,000 results (0.27s) 
    Ctrl+Shift+X to select

    Search Results

    AI Overview

    An AI Overview is not available for this searchCan't generate an AI overview right now. Try again later.
    AI Overview
    Liraglutide's side chain is
    a palmitoyl group (a C16 fatty acid) linked to a γ-glutamic acid spacer, which is then attached to the lysine at position 20 of the peptide. This fatty acid side chain allows the drug to bind to albumin in the blood, which prolongs its half-life and enables it to be administered once daily. 
    Key components of the side chain 
    • Palmitoyl group: A 16-carbon fatty acid chain.
    • γ-Glutamic acid spacer: This is the intermediate molecule that connects the palmitoyl group to the peptide.
    • Lysine 20: The specific amino acid in the liraglutide peptide where the side chain is attached. 
    Function of the side chain 
    • Albumin binding: The fatty acid portion of the side chain allows liraglutide to bind to albumin, the main protein in blood plasma.
    • Prolonged half-life: This binding creates a reservoir of the drug in the body, preventing it from being eliminated quickly and extending its half-life to approximately 13 hours.
    • Once-daily dosing: The extended half-life is what makes a once-daily injection schedule possible for managing type 2 diabetes and obesity. 
    • Long Acting GLP-1 Receptor Agonist Drugs Lists and Overview
      Nov 11, 2021 — The albumin-bound bulk forms a reservoir promoting prolonged action. Overall, the elimination half-life is approximate...
      Biopharma PEG
    • (D-His1)-Liraglutide - GLP1 receptor agonist
      Structure of (D-His1)-Liraglutide Peptide. (D-His1)-Liraglutide is a 31-amino-acid peptide analogue of liraglutide and, therefore,
      JPT Peptide Technologies
    • Pal-Glu(OSu)-OH | Liraglutide Side Chain | MedChemExpress
      Pal-Glu(OSu)-OH is a side chain of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used...
      MedchemExpress.com
    • Characterizing the D-Amino Acid Position in Peptide Epimers ... - MDPI
      Jan 23, 2024 — 2. Results * 2.1. Analytical Procedure. Liraglutide contains thirty-one amino acids (1-HAEGTFTSDVSSYLEGNAAKEFIAWLVRGRG...
      MDPI
    • Liraglutide API Manufacturer & Supplier - Bachem
      Oct 25, 2022 — Liraglutide is a long-acting peptide analog of GLP-1, because of a better resistance to DDP-IV-mediated degradation du...
      Bachem
    • Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic
      Jul 31, 2025 — Description. Liraglutide injection is used with diet and exercise to lower blood sugar in people with type 2 diabetes.
      Mayo Clinic
    • Lipid regulation of the glucagon receptor family in: Journal of Endocrinology Volume 261 Issue 3 (2024)
      MEDI0382 and SAR425899 are both palmitoylated with a 16-carbon palmitic acid with a γ-carboxylate spacer at lysine 10 and 14, resp...
      Journal of Endocrinology
    • Long Acting GLP-1 Receptor Agonist Drugs Lists and Overview
      Nov 11, 2021 — The albumin-bound bulk forms a reservoir promoting prolonged action. Overall, the elimination half-life is approximate...
      Biopharma PEG
    • (D-His1)-Liraglutide - GLP1 receptor agonist
      Structure of (D-His1)-Liraglutide Peptide. (D-His1)-Liraglutide is a 31-amino-acid peptide analogue of liraglutide and, therefore,
      JPT Peptide Technologies
    • Pal-Glu(OSu)-OH | Liraglutide Side Chain | MedChemExpress
      Pal-Glu(OSu)-OH is a side chain of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used...
      MedchemExpress.com
    Show all
    Dive deeper in AI Mode
    This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
    Positive feedback
    Negative feedback
    Thank you
    Your feedback helps Google improve. See our Privacy Policy.
    Share more feedbackReport a problemClose
    Show more
    Explain this
    Related images
    Copy text
    Access this menu with Ctrl+Shift+X
    My Ad Center

    Pal-Glu(OSu)-OH | Liraglutide Side Chain


    MedchemExpress.com
    https://www.medchemexpress.com › pal-glu-osu-oh
    MedchemExpress.com
    https://www.medchemexpress.com › pal-glu-osu-oh
    Pal-Glu(OSu)-OH is a side chain of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used for type 2 diabetes mellitus ...
    Liraglutide Side Chain from www.medchemexpress.com
    Free delivery · 30-day returns

    Liraglutide Side Chain [Pal-Glu(OSu)-OtBu] Cas:204521- ...


    SINOPEG
    https://www.sinopeg.com › Liraglutide Intermediate
    SINOPEG
    https://www.sinopeg.com › Liraglutide Intermediate
    Liraglutide is made by attaching a C-16 fatty acid (palmitic acid) with a glutamic acid spacer on the remaining lysine residue at position 26 of the peptide ...
    Liraglutide Side Chain from www.sinopeg.com
    Images
    Liraglutide Side Chain [Pal-Glu(OSu)-OtBu] Cas:204521-63-1 ...
    Liraglutide Side Chain [Pal-Glu(OSu)-OtBu] Cas:204521-63-1 ...
    SINOPEG
    Pal-Glu(OSu)-OH
    Pal-Glu(OSu)-OH
    MedchemExpress.com
    The structures of fatty acid side chains of liraglutide and ...
    The structures of fatty acid side chains of liraglutide and ...
    ResearchGate
    α-Glu(side chain)-Liraglutide
    α-Glu(side chain)-Liraglutide
    Daicel Pharma Standards
    PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined ...
    PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined ...
    PDB-101 - RCSB PDB
    α-Glu(side chain)-Liraglutide
    α-Glu(side chain)-Liraglutide
    Pharmaffiliates
    α-Glu(side chain)-Liraglutide - Daicel Pharma Standards
    α-Glu(side chain)-Liraglutide - Daicel Pharma Standards
    Daicel Pharma Standards
    The structures of fatty acid side chains of liraglutide and ...
    The structures of fatty acid side chains of liraglutide and ...
    ResearchGate
    WO2020182227A1 - Preparation method for high purity ...
    WO2020182227A1 - Preparation method for high purity ...
    Google Patents

    All images

    Show more images

    Liraglutide | C172H265N43O51 | CID 16134956 - PubChem


    National Institutes of Health (.gov)
    https://pubchem.ncbi.nlm.nih.gov › compound › Liragl...
    National Institutes of Health (.gov)
    https://pubchem.ncbi.nlm.nih.gov › compound › Liragl...
    Liraglutide is a lipopeptide that is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group.

    The structures of fatty acid side chains of liraglutide and ...


    ResearchGate
    https://www.researchgate.net › figure › The-structures-o...
    ResearchGate
    https://www.researchgate.net › figure › The-structures-o...
    These include significant reductions in body weight, improvements in lipid profiles, decreased blood pressure, and attenuation of hepatic steatosis. Emerging ...
    Liraglutide Side Chain from www.researchgate.net

    α-Glu(side chain)-Liraglutide


    Daicel Pharma Standards
    https://www.daicelpharmastandards.com › ... › GLP-1
    Daicel Pharma Standards
    https://www.daicelpharmastandards.com › ... › GLP-1
    Buy α-Glu(side chain)-Liraglutide from Daicel Pharma Standards , the leading Pharmaceutical Impurities Manufacturer and Supplier.
    Liraglutide Side Chain from www.daicelpharmastandards.com

    Preparation method for high purity liraglutide side chain


    Google Patents
    https://patents.google.com › patent
    Google Patents
    https://patents.google.com › patent
    The preparation method for high purity liraglutide side chain has a simple operation, a short synthesis cycle, low costs and easy post-processing.

    Peptide Blockbusters Liraglutide and Semaglutide


    Iris Biotech GmbH
    https://iris-biotech.de › global › blog › peptide-blockbu...
    Iris Biotech GmbH
    https://iris-biotech.de › global › blog › peptide-blockbu...
    Apr 6, 2022 — Both are long-acting analogs of the linear glucagon-like peptide-1 (GLP-1) modified with a fatty acid side chain to be more stable against ...

    (D-His1)-Liraglutide - GLP1 receptor agonist


    JPT Peptide Technologies
    https://www.jpt.com › SP-CAT-036
    JPT Peptide Technologies
    https://www.jpt.com › SP-CAT-036
    It retains liraglutide's overall structure, including the C16 palmitic acid side chain attached via a γ-glutamic acid spacer to Lys26, which promotes ...
    $978.00

    Glucagon-like peptide-1 receptor: mechanisms and ...


    Nature
    https://www.nature.com › ... › review articles
    Nature
    https://www.nature.com › ... › review articles
    by Z Zheng · 2024 · Cited by 526 — Liraglutide has an arginine at position 34 (GLP-1(7-37)) that is lysine, and its lysine at position 26 connects to a 16-carbon palmitic acid ...
    People also search for
    Liraglutide side chain price
    Liraglutide side chain for sale
    Liraglutide mechanism of action
    Liraglutide mass
    Liraglutide peptide sequence
    Liraglutide side effects
    Liraglutide pka
    Liraglutide molecular weight kda

    Page Navigation

    12345678910Next

    Footer Links

    Metro Vancouver, British Columbia, Canada
     - Based on your past activity
     - 
    Update location
    Can't update your location
    Learn more
    Updating location...
    HelpSend feedbackPrivacyTerms
    Google apps
    AI overview is ready